🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT03821142
Active, not recruiting Not applicable

Prospective Long-term Evaluation of the Efficacy and Safety of Calistar S for Transvaginal Pelvic Organ Prolapse Repair

NCT03821142 · tracked via the Priya Life Science Germany tracker
Sponsor
Promedon
Phase
Not applicable
Started
2021-03-10
Last updated
2024-11-22

Condition(s) studied

Pelvic Organ Prolapse

Investigational drug(s) / intervention(s)

Transvaginal mesh for anterior pelvic organ prolapse repair

Transvaginal mesh for anterior pelvic organ prolapse repair: synthetic mesh for anterior pelvic organ prolapse with or without apical vaginal wall involvement via the vaginal route in a highly selected patient population

Study summary

Prospective long-term evaluation of the performance and safety of Calistar S for transvaginal pelvic organ prolapse repair in women with anterior POP with or without apical vaginal involvement

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion criteria Non-fertile women \> 18 years1 2. Symtomatic anterior prolapse with or without apical vaginal wall involvement according POP-Q score ≥ 2. (Corresponding to Aa, Ba ≥ -1 and where applicable C ≥ -1/2 TVL ). 3\. Subjects with recurrent prolapse or complex primary prolapse are eligible for the study. 4\. Scheduled mesh-augmented anterior POP repair with Calistar S 5. Signed inform consent Exclusion criteria 1. Fertile women 2. Patients with active or latent infection of the vagina, cervix or uterus 3. Patients with previous or current vaginal, cervical or uterine cancer 4. Previous, current or planned pelvic radiation therapy 5. Known allergy to polypropylene 7\. Subject is unable or unwilling to complete questionnaires (either self-administered, assisted or interviewed) and/or to follow scheduled visits and/or to sign informed consent

Primary outcome measure(s)

Trial sites (6)

FacilityCityRegionStatus
Helios Hospital Erfurt, Department of gynaecology Erfurt Thuringia
St. Hedwig Hospital Berlin Germany
Evangelic Diakonie Hospital Freiburg im Breisgau Germany
St. Elisabeth-Hospital Leipzig Leipzig Germany
Hospital Tettnang Tettnang Germany
University Hospital Tübingen Tübingen Germany

More Promedon trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03821142 on ClinicalTrials.gov ↗ ← All trials in Germany